Meanwhile, the effects of Rbm24 overexpression were hindered by the Notch1 inhibitor DAPT, suggesting Notch1 as a downstream target of Rbm24 in SVZ neurogenesis during PD pathogenesis. This evidence concerns the gene RBM24 and Parkinson disease.